Published in Cancer Epidemiol Biomarkers Prev on August 16, 2011
Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization. BMC Pregnancy Childbirth (2013) 0.83
Anti-HE4 antibodies in infertile women and women with ovarian cancer. Gynecol Oncol (2013) 0.76
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell (2005) 5.79
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med (2008) 5.19
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06
The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril (2008) 3.00
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res (2005) 2.98
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci U S A (1999) 2.87
Mesothelin variant 1 is released from tumor cells as a diagnostic marker. Cancer Epidemiol Biomarkers Prev (2006) 2.77
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.43
Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet (1999) 2.39
Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol (2005) 2.34
Premature ovarian failure. Hum Reprod Update (2005) 2.31
Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev (2008) 2.30
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer (1999) 2.26
Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ (2009) 2.08
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients. Clin Cancer Res (2005) 2.05
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol (2002) 2.02
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res (2006) 1.99
Systematic evaluation of candidate blood markers for detecting ovarian cancer. PLoS One (2008) 1.93
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol (2004) 1.88
A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother (2009) 1.75
Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst (1983) 1.71
Assisted reproductive technology surveillance--United States, 2006. MMWR Surveill Summ (2009) 1.70
Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol (1990) 1.62
The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer (2009) 1.60
Ovarian cancer risk associated with varying causes of infertility. Fertil Steril (2004) 1.52
Ovarian tumors of the hen. Environ Health Perspect (1987) 1.48
Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A (2010) 1.46
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum Pathol (2003) 1.44
Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. J Immunol Methods (2008) 1.43
SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other. Adv Exp Med Biol (2008) 1.40
Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol (2009) 1.34
Causes of infertility as predictors of subsequent cancer risk. Epidemiology (2005) 1.26
Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo. Adv Immunol (2006) 1.21
Management of the infertile couple: an evidence-based protocol. Reprod Biol Endocrinol (2010) 1.20
Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol (2009) 1.17
Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene (2003) 1.16
Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta (2006) 1.14
Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol (2001) 1.11
Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.11
Ovarian carcinogenesis: an alternative hypothesis. Adv Exp Med Biol (2008) 1.09
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer. Clin Cancer Res (2009) 1.08
A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol (2004) 1.08
Loss of ovarian function and the risk of ovarian cancer. Cell Tissue Res (2005) 1.07
Malignancies among women who gave birth after in vitro fertilization. Hum Reprod (2010) 1.07
Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update (2004) 1.07
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod (2000) 1.06
Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. Cancer Res (2006) 1.06
Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion. Lancet Oncol (2008) 1.02
A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett (2008) 1.02
Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens. Expert Rev Mol Diagn (2005) 1.01
The flip side of immune surveillance: immune dependency. Immunol Rev (2008) 1.01
Stimulation of cells by antibody. Science (1973) 0.99
Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med (2002) 0.98
Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab (1990) 0.97
Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. Eur J Cancer (2010) 0.96
Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients. Cancer Epidemiol Biomarkers Prev (2008) 0.96
An immune reaction may be necessary for cancer development. Theor Biol Med Model (2006) 0.94
Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both? Cancer Immunol Immunother (2008) 0.93
MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis. BMC Cancer (2006) 0.93
Anti-tumor antibodies in ovarian cancer. Am J Reprod Immunol (2005) 0.92
Application of destabilizing sequences on selection marker for improved recombinant protein productivity in CHO-DG44. Metab Eng (2007) 0.92
The epidemiology of ovarian cancer. J Cell Biochem Suppl (1995) 0.91
Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer. Am J Reprod Immunol (2007) 0.89
A block in the road to fertility: autoantibodies to heat-shock protein 90-beta in human ovarian autoimmunity. Fertil Steril (2008) 0.89
Detection of circulating mammary mucin (Muc1) and MUC1 immune complexes (Muc1-CIC) in healthy women. Int J Biol Markers (2001) 0.89
Alpha-enolase: a novel autoantigen in patients with premature ovarian failure. Clin Endocrinol (Oxf) (2006) 0.88
CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clin Chem (2010) 0.87
Diagnostic criteria for polycystic ovarian syndrome. Endocrine (2006) 0.87
A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry. Fertil Steril (2009) 0.87
Mumps, menarche, menopause, and ovarian cancer. Am J Obstet Gynecol (1983) 0.86
Research on the mechanisms of premature ovarian failure. J Soc Gynecol Investig (2001) 0.86
MUC1 in endometriosis and ovarian cancer. Immunol Res (2006) 0.86
Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays. Clin Biochem (2008) 0.86
Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation. Eur J Cancer (2007) 0.85
Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril (2010) 0.85
Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol (1999) 0.83
Epidemiologic aspects of early menopause and ovarian cancer. Ann N Y Acad Sci (1990) 0.83
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors. J Ovarian Res (2011) 0.80
Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies. Hum Reprod (2002) 0.80
Ovarian antibodies, FSH and inhibin B: independent markers associated with unexplained infertility. Hum Reprod (2000) 0.79
Cancer risks associated with the diagnosis of infertility. Best Pract Res Clin Obstet Gynaecol (2003) 0.78
Association of unexplained infertility with gonadotropin and ovarian antibodies. Am J Reprod Immunol (2006) 0.78
[Ovarian autoimmunity and ovarian pathologies: antigenic targets and diagnostic significance]. J Gynecol Obstet Biol Reprod (Paris) (2005) 0.76
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A (2010) 4.95
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet (2011) 3.55
Mesothelin-family proteins and diagnosis of mesothelioma. Lancet (2003) 2.98
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res (2004) 2.96
JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci U S A (2007) 2.45
Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol (2005) 2.34
2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest (2013) 2.15
A Drosophila model for LRRK2-linked parkinsonism. Proc Natl Acad Sci U S A (2008) 2.12
Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. Epidemiology (2012) 2.01
Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis (2007) 1.99
Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet (2006) 1.94
Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications. Chem Biol (2009) 1.93
Performance of random forest when SNPs are in linkage disequilibrium. BMC Bioinformatics (2009) 1.81
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet (2013) 1.77
CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood (2010) 1.70
Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology (2011) 1.61
Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology (2010) 1.58
Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection. J Exp Med (2006) 1.55
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res (2006) 1.54
Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A (2012) 1.44
Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer (2009) 1.43
A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J (2011) 1.42
Effects of burial in sand and water supply regime on seedling emergence of six species. Ann Bot (2005) 1.39
WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res (2006) 1.39
The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth. J Biol Chem (2010) 1.38
Functional analysis of the validamycin biosynthetic gene cluster and engineered production of validoxylamine A. Chem Biol (2006) 1.33
MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem (2007) 1.27
The plant signal salicylic acid shuts down expression of the vir regulon and activates quormone-quenching genes in Agrobacterium. Proc Natl Acad Sci U S A (2007) 1.25
Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharm Biotechnol (2006) 1.25
Nanoscale dewetting transition in protein complex folding. J Phys Chem B (2007) 1.22
The multiscale coarse-graining method. II. Numerical implementation for coarse-grained molecular models. J Chem Phys (2008) 1.20
ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol (2010) 1.19
Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol (2008) 1.16
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol (2012) 1.15
Complement factor D in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.14
Characterization of the azinomycin B biosynthetic gene cluster revealing a different iterative type I polyketide synthase for naphthoate biosynthesis. Chem Biol (2008) 1.13
Ionic liquid-based ultrasonic-assisted extraction of piperine from white pepper. Anal Chim Acta (2009) 1.13
Serial replica exchange. J Phys Chem B (2007) 1.11
Radical-mediated enzymatic carbon chain fragmentation-recombination. Nat Chem Biol (2011) 1.09
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer. Clin Cancer Res (2009) 1.08
Moving posttranslational modifications forward to biosynthesize the glycosylated thiopeptide nocathiacin I in Nocardia sp. ATCC202099. Mol Biosyst (2010) 1.08
PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res (2010) 1.08
Identification and analysis of the biosynthetic gene cluster encoding the thiopeptide antibiotic cyclothiazomycin in Streptomyces hygroscopicus 10-22. Appl Environ Microbiol (2010) 1.08
A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy. Am J Obstet Gynecol (2006) 1.06
Soluble mesothelin-related protein--a blood test for mesothelioma. Lung Cancer (2005) 1.06
Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation. J Immunother (2013) 1.04
Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry (2009) 1.03
Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans? J Ultrasound Med (2007) 1.03
Cotransplantation with specific populations of spina bifida bone marrow stem/progenitor cells enhances urinary bladder regeneration. Proc Natl Acad Sci U S A (2013) 1.03
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett (2010) 1.01
ORACLE INEQUALITIES FOR THE LASSO IN THE COX MODEL. Ann Stat (2013) 1.01
Mechanistic studies of water electrolysis and hydrogen electro-oxidation on high temperature ceria-based solid oxide electrochemical cells. J Am Chem Soc (2013) 1.00
Production and characterization of a novel bioflocculant from Bacillus licheniformis. Appl Environ Microbiol (2010) 0.99
Photoautotrophic production of D-lactic acid in an engineered cyanobacterium. Microb Cell Fact (2013) 0.99
Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc (2013) 0.98
Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy. J Am Chem Soc (2010) 0.98
Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors. J Ovarian Res (2010) 0.98
Progression and prognosis of gastric stump cancer. J Surg Oncol (2009) 0.97
Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients. Cancer Epidemiol Biomarkers Prev (2008) 0.96
Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol (2013) 0.96
Functional characterization of Gossypium hirsutum profilin 1 gene (GhPFN1) in tobacco suspension cells. Characterization of in vivo functions of a cotton profilin gene. Planta (2005) 0.95
miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. Int J Mol Med (2013) 0.95
Solution-Phase Synthesis of Cesium Lead Halide Perovskite Nanowires. J Am Chem Soc (2015) 0.95
Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment. Cancer Res (2007) 0.94
Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis (2005) 0.93
Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137. Proc Natl Acad Sci U S A (2004) 0.93
MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumour Biol (2012) 0.92
Administration of cyclophosphamide changes the immune profile of tumor-bearing mice. J Immunother (2010) 0.91
Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Pharmacol Res (2011) 0.91
ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Autophagy (2014) 0.90
Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma. J Immunother (2012) 0.90
Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer. Am J Reprod Immunol (2007) 0.89
Therapeutic vaccination with tumor cells that engage CD137. J Mol Med (Berl) (2003) 0.89
Coordinated regulation of active and repressive histone methylations by a dual-specificity histone demethylase ceKDM7A from Caenorhabditis elegans. Cell Res (2010) 0.89
Identification of genes necessary for jinggangmycin biosynthesis from Streptomyces hygroscopicus 10-22. Antonie Van Leeuwenhoek (2006) 0.89
Confirmation and generalization of an alcohol-dependence locus on chromosome 10q. Neuropsychopharmacology (2010) 0.88
Prevalence of antitumor antibodies in laying hen model of human ovarian cancer. Int J Gynecol Cancer (2009) 0.88
Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice. Hepatology (2011) 0.88
Phase-selective cation-exchange chemistry in sulfide nanowire systems. J Am Chem Soc (2014) 0.88
The Chinese healthcare system: structure, problems and challenges. Appl Health Econ Health Policy (2011) 0.87
Identification of constant-posture EMG-torque relationship about the elbow using nonlinear dynamic models. IEEE Trans Biomed Eng (2011) 0.87
Directional Fano resonance in a silicon nanosphere dimer. ACS Nano (2015) 0.87
The fish pathogen Yersinia ruckeri produces holomycin and uses an RNA methyltransferase for self-resistance. J Biol Chem (2013) 0.87
IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN. J Immunol (2013) 0.86
Ionothermal synthesis of hexagonal-phase NaYF(4):Yb(3+),Er(3+)/Tm(3+) upconversion nanophosphors. Chem Commun (Camb) (2009) 0.86
Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. Eur J Neurosci (2002) 0.86
A microfibre assembly of an iron-carbon composite with giant magnetisation. Sci Rep (2013) 0.86
π-π interaction assisted hydrodefluorination of perfluoroarenes by gold hydride: a case of synergistic effect on C-F bond activation. J Am Chem Soc (2012) 0.85
Luminescent zinc salen complexes as single and two-photon fluorescence subcellular imaging probes. Chem Commun (Camb) (2010) 0.85
Citrate synthase mutants of Agrobacterium are attenuated in virulence and display reduced vir gene induction. J Bacteriol (2005) 0.85
Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril (2010) 0.85
Vaccines to treat cancer--an old approach whose time has arrived. J Cell Biochem (2007) 0.85